Helius Medical Technologies Stock Alpha and Beta Analysis

HSDT Stock  USD 0.45  0.02  4.65%   
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Helius Medical Technologies. It also helps investors analyze the systematic and unsystematic risks associated with investing in Helius Medical over a specified time horizon. Remember, high Helius Medical's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Helius Medical's market risk premium analysis include:
Beta
3.09
Alpha
(0.75)
Risk
9.17
Sharpe Ratio
(0.05)
Expected Return
(0.47)
Please note that although Helius Medical alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., Dow Jones Industrial index.) So in this particular case, Helius Medical did 0.75  worse than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of Helius Medical Technologies stock's relative risk over its benchmark. Helius Medical Techn has a beta of 3.09  . As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Helius Medical will likely underperform. At this time, Helius Medical's Enterprise Value Over EBITDA is comparatively stable compared to the past year. Price Book Value Ratio is likely to gain to 2.18 in 2024, despite the fact that Enterprise Value is likely to grow to (225.7 K).

Enterprise Value

(225,686)

Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
  
Check out Helius Medical Backtesting, Helius Medical Valuation, Helius Medical Correlation, Helius Medical Hype Analysis, Helius Medical Volatility, Helius Medical History and analyze Helius Medical Performance.

Helius Medical Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Helius Medical market risk premium is the additional return an investor will receive from holding Helius Medical long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Helius Medical. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Helius Medical's performance over market.
α-0.75   β3.09

Helius Medical expected buy-and-hold returns

Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Helius Medical's Buy-and-hold return. Our buy-and-hold chart shows how Helius Medical performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.

Helius Medical Market Price Analysis

Market price analysis indicators help investors to evaluate how Helius Medical stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Helius Medical shares will generate the highest return on investment. By understating and applying Helius Medical stock market price indicators, traders can identify Helius Medical position entry and exit signals to maximize returns.

Helius Medical Return and Market Media

The median price of Helius Medical for the period between Sun, Aug 25, 2024 and Sat, Nov 23, 2024 is 0.56 with a coefficient of variation of 23.32. The daily time series for the period is distributed with a sample standard deviation of 0.15, arithmetic mean of 0.62, and mean deviation of 0.13. The Stock received substential amount of media coverage during this period.
 Price Growth (%)  
       Timeline  
1
Helius Medical Technologies, Inc. Announces Positive Preliminary Results of the PoNSTEP Study
09/30/2024
2
Helius Medical Technologies, Inc. to Present at the 2024 ThinkEquity Conference
10/18/2024
3
Helius Medical Technologies Faces Nasdaq Delisting Risk Due to Stock Price Non-Compliance - TipRanks
11/13/2024
4
Helius Medical Technologies, Inc. Provides Updates on Efforts to Achieve Fair Market Access for its Portable Neuromodulation Stimulator Device
11/18/2024
5
Helius Medical Technologies Initiates Strategic Alternatives to Maximize Stockholder ValueNEWTOWN, Pa., Nov. 18, 2024 Helius Medical Technologies, Inc. announce...
11/21/2024

About Helius Medical Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Helius or other stocks. Alpha measures the amount that position in Helius Medical Techn has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
 2021 2022 2023 2024 (projected)
Payables Turnover0.280.741.11.15
Days Of Inventory On Hand583.02464.33286.11313.18

Helius Medical Upcoming Company Events

As portrayed in its financial statements, the presentation of Helius Medical's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Helius Medical's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Helius Medical's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Helius Medical. Please utilize our Beneish M Score to check the likelihood of Helius Medical's management manipulating its earnings.
14th of March 2024
Upcoming Quarterly Report
View
9th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
14th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Build Portfolio with Helius Medical

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations

Additional Tools for Helius Stock Analysis

When running Helius Medical's price analysis, check to measure Helius Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Helius Medical is operating at the current time. Most of Helius Medical's value examination focuses on studying past and present price action to predict the probability of Helius Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Helius Medical's price. Additionally, you may evaluate how the addition of Helius Medical to your portfolios can decrease your overall portfolio volatility.